APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transmucosal Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transmucosal Drug Delivery Industry Growth and Trends Forecast to 2032

22 December 2025124 pages

Choose your research edition.

Industry ResearchTransmucosal Drug Delivery Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Transmucosal Drug Delivery Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Transmucosal Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transmucosal Drug Delivery Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Transmucosal Drug Delivery Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

According to APO Research, the global Transmucosal Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transmucosal Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transmucosal Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transmucosal Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Transmucosal Drug Delivery market include TEVA Pharmaceutical Industries Ltd., Mylan, Inc., Zosano Pharma, tesa Labtec GmbH, Tapemark, Pantec Biosolutions AG, Noven Pharmaceuticals, Inc., Nitto Denko Corporation and Nemaura Pharma Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transmucosal Drug Delivery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transmucosal Drug Delivery market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transmucosal Drug Delivery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transmucosal Drug Delivery.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Transmucosal Drug Delivery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transmucosal Drug Delivery Market by Company

TEVA Pharmaceutical Industries Ltd.

Mylan, Inc.

Zosano Pharma

tesa Labtec GmbH

Tapemark

Pantec Biosolutions AG

Noven Pharmaceuticals, Inc.

Nitto Denko Corporation

Nemaura Pharma Ltd

MedPharm LTD

Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

Inovio Pharmaceuticals, Inc.

Generex Biotechnology Corporation

DURECT Corporation

Corium International, Inc

Aveva Drug Delivery Systems

Apricus BioSciences, Inc

Antares Pharma, Inc.

ALZA Corporation

Acrux Limited

3M Pharmaceuticals

Transmucosal Drug Delivery Segment by Type

Passive Transdermal Drug Delivery

Active Transdermal Drug Delivery

Transmucosal Drug Delivery Segment by Application

Hospital

Clinic

Others

Transmucosal Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transmucosal Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transmucosal Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transmucosal Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Transmucosal Drug Delivery companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Transmucosal Drug Delivery Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Transmucosal Drug Delivery Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Transmucosal Drug Delivery Market Share by Region (2021-2026) Table 4. Global Transmucosal Drug Delivery Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Transmucosal Drug Delivery Market Share by Region (2027-2032) Table 6. Global Transmucosal Drug Delivery Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Transmucosal Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Transmucosal Drug Delivery Market Size Share by Type (2021-2026) Table 9. Global Transmucosal Drug Delivery Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Transmucosal Drug Delivery Market Size Share Forecasted by Type (2027-2032) Table 11. North America Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Transmucosal Drug Delivery Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Transmucosal Drug Delivery Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Transmucosal Drug Delivery Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Transmucosal Drug Delivery Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Transmucosal Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Transmucosal Drug Delivery Market Size Share by Application (2021-2026) Table 24. Global Transmucosal Drug Delivery Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Transmucosal Drug Delivery Market Size Share Forecasted by Application (2027-2032) Table 26. North America Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Transmucosal Drug Delivery Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Transmucosal Drug Delivery Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Transmucosal Drug Delivery Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Transmucosal Drug Delivery Industry Trends Table 37. Transmucosal Drug Delivery Industry Drivers Table 38. Transmucosal Drug Delivery Industry Opportunities and Challenges Table 39. Transmucosal Drug Delivery Industry Restraints Table 40. Global Transmucosal Drug Delivery Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Transmucosal Drug Delivery Revenue Market Share by Company (2021-2026) Table 42. Global Transmucosal Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Transmucosal Drug Delivery Key Company Headquarters & Area Served Table 44. Global Transmucosal Drug Delivery Company, Product Type & Application Table 45. Global Transmucosal Drug Delivery Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. TEVA Pharmaceutical Industries Ltd. Company Information Table 49. TEVA Pharmaceutical Industries Ltd. Business Overview Table 50. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Portfolio Table 52. TEVA Pharmaceutical Industries Ltd. Recent Development Table 53. Mylan, Inc. Company Information Table 54. Mylan, Inc. Business Overview Table 55. Mylan, Inc. Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Mylan, Inc. Transmucosal Drug Delivery Product Portfolio Table 57. Mylan, Inc. Recent Development Table 58. Zosano Pharma Company Information Table 59. Zosano Pharma Business Overview Table 60. Zosano Pharma Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Zosano Pharma Transmucosal Drug Delivery Product Portfolio Table 62. Zosano Pharma Recent Development Table 63. tesa Labtec GmbH Company Information Table 64. tesa Labtec GmbH Business Overview Table 65. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. tesa Labtec GmbH Transmucosal Drug Delivery Product Portfolio Table 67. tesa Labtec GmbH Recent Development Table 68. Tapemark Company Information Table 69. Tapemark Business Overview Table 70. Tapemark Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Tapemark Transmucosal Drug Delivery Product Portfolio Table 72. Tapemark Recent Development Table 73. Pantec Biosolutions AG Company Information Table 74. Pantec Biosolutions AG Business Overview Table 75. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pantec Biosolutions AG Transmucosal Drug Delivery Product Portfolio Table 77. Pantec Biosolutions AG Recent Development Table 78. Noven Pharmaceuticals, Inc. Company Information Table 79. Noven Pharmaceuticals, Inc. Business Overview Table 80. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Portfolio Table 82. Noven Pharmaceuticals, Inc. Recent Development Table 83. Nitto Denko Corporation Company Information Table 84. Nitto Denko Corporation Business Overview Table 85. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nitto Denko Corporation Transmucosal Drug Delivery Product Portfolio Table 87. Nitto Denko Corporation Recent Development Table 88. Nemaura Pharma Ltd Company Information Table 89. Nemaura Pharma Ltd Business Overview Table 90. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Nemaura Pharma Ltd Transmucosal Drug Delivery Product Portfolio Table 92. Nemaura Pharma Ltd Recent Development Table 93. MedPharm LTD Company Information Table 94. MedPharm LTD Business Overview Table 95. MedPharm LTD Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MedPharm LTD Transmucosal Drug Delivery Product Portfolio Table 97. MedPharm LTD Recent Development Table 98. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Information Table 99. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview Table 100. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Portfolio Table 102. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development Table 103. Inovio Pharmaceuticals, Inc. Company Information Table 104. Inovio Pharmaceuticals, Inc. Business Overview Table 105. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Portfolio Table 107. Inovio Pharmaceuticals, Inc. Recent Development Table 108. Generex Biotechnology Corporation Company Information Table 109. Generex Biotechnology Corporation Business Overview Table 110. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Generex Biotechnology Corporation Transmucosal Drug Delivery Product Portfolio Table 112. Generex Biotechnology Corporation Recent Development Table 113. DURECT Corporation Company Information Table 114. DURECT Corporation Business Overview Table 115. DURECT Corporation Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. DURECT Corporation Transmucosal Drug Delivery Product Portfolio Table 117. DURECT Corporation Recent Development Table 118. Corium International, Inc Company Information Table 119. Corium International, Inc Business Overview Table 120. Corium International, Inc Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Corium International, Inc Transmucosal Drug Delivery Product Portfolio Table 122. Corium International, Inc Recent Development Table 123. Aveva Drug Delivery Systems Company Information Table 124. Aveva Drug Delivery Systems Business Overview Table 125. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Portfolio Table 127. Aveva Drug Delivery Systems Recent Development Table 128. Apricus BioSciences, Inc Company Information Table 129. Apricus BioSciences, Inc Business Overview Table 130. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Apricus BioSciences, Inc Transmucosal Drug Delivery Product Portfolio Table 132. Apricus BioSciences, Inc Recent Development Table 133. Antares Pharma, Inc. Company Information Table 134. Antares Pharma, Inc. Business Overview Table 135. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Antares Pharma, Inc. Transmucosal Drug Delivery Product Portfolio Table 137. Antares Pharma, Inc. Recent Development Table 138. ALZA Corporation Company Information Table 139. ALZA Corporation Business Overview Table 140. ALZA Corporation Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. ALZA Corporation Transmucosal Drug Delivery Product Portfolio Table 142. ALZA Corporation Recent Development Table 143. Acrux Limited Company Information Table 144. Acrux Limited Business Overview Table 145. Acrux Limited Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Acrux Limited Transmucosal Drug Delivery Product Portfolio Table 147. Acrux Limited Recent Development Table 148. 3M Pharmaceuticals Company Information Table 149. 3M Pharmaceuticals Business Overview Table 150. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. 3M Pharmaceuticals Transmucosal Drug Delivery Product Portfolio Table 152. 3M Pharmaceuticals Recent Development Table 153. North America Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Transmucosal Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Transmucosal Drug Delivery Market Share by Country (2021-2026) Table 156. North America Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Transmucosal Drug Delivery Market Share Forecast by Country (2027-2032) Table 158. Europe Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Transmucosal Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Transmucosal Drug Delivery Market Share by Country (2021-2026) Table 161. Europe Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Transmucosal Drug Delivery Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Transmucosal Drug Delivery Market Share by Country (2021-2026) Table 166. Asia-Pacific Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Transmucosal Drug Delivery Market Share Forecast by Country (2027-2032) Table 168. Latin America Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Transmucosal Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Transmucosal Drug Delivery Market Share by Country (2021-2026) Table 171. Latin America Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Transmucosal Drug Delivery Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Transmucosal Drug Delivery Market Share by Country (2021-2026) Table 176. Middle East & Africa Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Transmucosal Drug Delivery Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Transmucosal Drug Delivery Product Image Figure 3. Global Transmucosal Drug Delivery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Transmucosal Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 5. Global Transmucosal Drug Delivery Market Share by Region: 2025 VS 2032 Figure 6. Global Transmucosal Drug Delivery Market Share by Region (2021-2032) Figure 7. North America Transmucosal Drug Delivery Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Transmucosal Drug Delivery Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Transmucosal Drug Delivery Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Transmucosal Drug Delivery Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Transmucosal Drug Delivery Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Passive Transdermal Drug Delivery Image Figure 13. Global Passive Transdermal Drug Delivery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Active Transdermal Drug Delivery Image Figure 15. Global Active Transdermal Drug Delivery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Transmucosal Drug Delivery Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Transmucosal Drug Delivery Market Share by Type 2025 VS 2032 Figure 18. North America Transmucosal Drug Delivery Market Size Share by Type (2021-2032) Figure 19. Europe Transmucosal Drug Delivery Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Transmucosal Drug Delivery Market Size Share by Type (2021-2032) Figure 21. Latin America Transmucosal Drug Delivery Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Transmucosal Drug Delivery Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Transmucosal Drug Delivery Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Transmucosal Drug Delivery Market Share by Application 2025 VS 2032 Figure 31. North America Transmucosal Drug Delivery Market Size Share by Application (2021-2032) Figure 32. Europe Transmucosal Drug Delivery Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Transmucosal Drug Delivery Market Size Share by Application (2021-2032) Figure 34. Latin America Transmucosal Drug Delivery Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Transmucosal Drug Delivery Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Transmucosal Drug Delivery Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Transmucosal Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Transmucosal Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Transmucosal Drug Delivery Market Share by Country (2021-2032) Figure 41. Europe Transmucosal Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Transmucosal Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Transmucosal Drug Delivery Market Share by Country (2021-2032) Figure 44. Asia-Pacific Transmucosal Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Transmucosal Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Transmucosal Drug Delivery Market Share by Country (2021-2032) Figure 47. Latin America Transmucosal Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Transmucosal Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Transmucosal Drug Delivery Market Share by Country (2021-2032) Figure 50. Middle East & Africa Transmucosal Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Transmucosal Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Transmucosal Drug Delivery Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Passive Transdermal Drug Delivery
  • Active Transdermal Drug Delivery
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • TEVA Pharmaceutical Industries Ltd.
  • Mylan, Inc.
  • Zosano Pharma
  • tesa Labtec GmbH
  • Tapemark
  • Pantec Biosolutions AG
  • Noven Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Nemaura Pharma Ltd
  • MedPharm LTD
  • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  • Inovio Pharmaceuticals, Inc.
  • Generex Biotechnology Corporation
  • DURECT Corporation
  • Corium International, Inc
  • Aveva Drug Delivery Systems
  • Apricus BioSciences, Inc
  • Antares Pharma, Inc.
  • ALZA Corporation
  • Acrux Limited
  • 3M Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Transmucosal Drug Delivery Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Transmucosal Drug Delivery Market Size by Region (2021-2032)
  5. 1.4.1 Global Transmucosal Drug Delivery Market Size by Region (2021-2026)
  6. 1.4.2 Global Transmucosal Drug Delivery Market Size by Region (2027-2032)
  7. 1.5 Key Regions Transmucosal Drug Delivery Market Size (2021-2032)
  8. 1.5.1 North America Transmucosal Drug Delivery Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Transmucosal Drug Delivery Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Transmucosal Drug Delivery Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Transmucosal Drug Delivery Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Transmucosal Drug Delivery Market Size Growth Rate (2021-2032)
2 Transmucosal Drug Delivery Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Passive Transdermal Drug Delivery
  3. 2.1.2 Active Transdermal Drug Delivery
  4. 2.2 Global Transmucosal Drug Delivery Market Size by Type
  5. 2.2.1 Global Transmucosal Drug Delivery Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Transmucosal Drug Delivery Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Transmucosal Drug Delivery Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Transmucosal Drug Delivery Market Size by Regions
  9. 2.3.1 North America Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Type (2021-2026)
3 Transmucosal Drug Delivery Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Transmucosal Drug Delivery Market Size by Application
  6. 3.2.1 Global Transmucosal Drug Delivery Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Transmucosal Drug Delivery Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Transmucosal Drug Delivery Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Transmucosal Drug Delivery Market Size by Regions
  10. 3.3.1 North America Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Transmucosal Drug Delivery Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Transmucosal Drug Delivery Industry Trends
  2. 4.2 Transmucosal Drug Delivery Industry Drivers
  3. 4.3 Transmucosal Drug Delivery Industry Opportunities and Challenges
  4. 4.4 Transmucosal Drug Delivery Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Transmucosal Drug Delivery Revenue (2021-2026)
  2. 5.2 Global Transmucosal Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Transmucosal Drug Delivery Key Company Headquarters & Area Served
  4. 5.4 Global Transmucosal Drug Delivery Company, Product Type & Application
  5. 5.5 Global Transmucosal Drug Delivery Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Transmucosal Drug Delivery Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Transmucosal Drug Delivery Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Transmucosal Drug Delivery Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 TEVA Pharmaceutical Industries Ltd.
  2. 6.1.1 TEVA Pharmaceutical Industries Ltd. Company Information
  3. 6.1.2 TEVA Pharmaceutical Industries Ltd. Business Overview
  4. 6.1.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Portfolio
  6. 6.1.5 TEVA Pharmaceutical Industries Ltd. Recent Developments
  7. 6.2 Mylan, Inc.
  8. 6.2.1 Mylan, Inc. Company Information
  9. 6.2.2 Mylan, Inc. Business Overview
  10. 6.2.3 Mylan, Inc. Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Mylan, Inc. Transmucosal Drug Delivery Product Portfolio
  12. 6.2.5 Mylan, Inc. Recent Developments
  13. 6.3 Zosano Pharma
  14. 6.3.1 Zosano Pharma Company Information
  15. 6.3.2 Zosano Pharma Business Overview
  16. 6.3.3 Zosano Pharma Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Zosano Pharma Transmucosal Drug Delivery Product Portfolio
  18. 6.3.5 Zosano Pharma Recent Developments
  19. 6.4 tesa Labtec GmbH
  20. 6.4.1 tesa Labtec GmbH Company Information
  21. 6.4.2 tesa Labtec GmbH Business Overview
  22. 6.4.3 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 tesa Labtec GmbH Transmucosal Drug Delivery Product Portfolio
  24. 6.4.5 tesa Labtec GmbH Recent Developments
  25. 6.5 Tapemark
  26. 6.5.1 Tapemark Company Information
  27. 6.5.2 Tapemark Business Overview
  28. 6.5.3 Tapemark Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Tapemark Transmucosal Drug Delivery Product Portfolio
  30. 6.5.5 Tapemark Recent Developments
  31. 6.6 Pantec Biosolutions AG
  32. 6.6.1 Pantec Biosolutions AG Company Information
  33. 6.6.2 Pantec Biosolutions AG Business Overview
  34. 6.6.3 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pantec Biosolutions AG Transmucosal Drug Delivery Product Portfolio
  36. 6.6.5 Pantec Biosolutions AG Recent Developments
  37. 6.7 Noven Pharmaceuticals, Inc.
  38. 6.7.1 Noven Pharmaceuticals, Inc. Company Information
  39. 6.7.2 Noven Pharmaceuticals, Inc. Business Overview
  40. 6.7.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Portfolio
  42. 6.7.5 Noven Pharmaceuticals, Inc. Recent Developments
  43. 6.8 Nitto Denko Corporation
  44. 6.8.1 Nitto Denko Corporation Company Information
  45. 6.8.2 Nitto Denko Corporation Business Overview
  46. 6.8.3 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nitto Denko Corporation Transmucosal Drug Delivery Product Portfolio
  48. 6.8.5 Nitto Denko Corporation Recent Developments
  49. 6.9 Nemaura Pharma Ltd
  50. 6.9.1 Nemaura Pharma Ltd Company Information
  51. 6.9.2 Nemaura Pharma Ltd Business Overview
  52. 6.9.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Product Portfolio
  54. 6.9.5 Nemaura Pharma Ltd Recent Developments
  55. 6.10 MedPharm LTD
  56. 6.10.1 MedPharm LTD Company Information
  57. 6.10.2 MedPharm LTD Business Overview
  58. 6.10.3 MedPharm LTD Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MedPharm LTD Transmucosal Drug Delivery Product Portfolio
  60. 6.10.5 MedPharm LTD Recent Developments
  61. 6.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  62. 6.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Information
  63. 6.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
  64. 6.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Portfolio
  66. 6.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
  67. 6.12 Inovio Pharmaceuticals, Inc.
  68. 6.12.1 Inovio Pharmaceuticals, Inc. Company Information
  69. 6.12.2 Inovio Pharmaceuticals, Inc. Business Overview
  70. 6.12.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Portfolio
  72. 6.12.5 Inovio Pharmaceuticals, Inc. Recent Developments
  73. 6.13 Generex Biotechnology Corporation
  74. 6.13.1 Generex Biotechnology Corporation Company Information
  75. 6.13.2 Generex Biotechnology Corporation Business Overview
  76. 6.13.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Product Portfolio
  78. 6.13.5 Generex Biotechnology Corporation Recent Developments
  79. 6.14 DURECT Corporation
  80. 6.14.1 DURECT Corporation Company Information
  81. 6.14.2 DURECT Corporation Business Overview
  82. 6.14.3 DURECT Corporation Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 DURECT Corporation Transmucosal Drug Delivery Product Portfolio
  84. 6.14.5 DURECT Corporation Recent Developments
  85. 6.15 Corium International, Inc
  86. 6.15.1 Corium International, Inc Company Information
  87. 6.15.2 Corium International, Inc Business Overview
  88. 6.15.3 Corium International, Inc Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Corium International, Inc Transmucosal Drug Delivery Product Portfolio
  90. 6.15.5 Corium International, Inc Recent Developments
  91. 6.16 Aveva Drug Delivery Systems
  92. 6.16.1 Aveva Drug Delivery Systems Company Information
  93. 6.16.2 Aveva Drug Delivery Systems Business Overview
  94. 6.16.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Portfolio
  96. 6.16.5 Aveva Drug Delivery Systems Recent Developments
  97. 6.17 Apricus BioSciences, Inc
  98. 6.17.1 Apricus BioSciences, Inc Company Information
  99. 6.17.2 Apricus BioSciences, Inc Business Overview
  100. 6.17.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Product Portfolio
  102. 6.17.5 Apricus BioSciences, Inc Recent Developments
  103. 6.18 Antares Pharma, Inc.
  104. 6.18.1 Antares Pharma, Inc. Company Information
  105. 6.18.2 Antares Pharma, Inc. Business Overview
  106. 6.18.3 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Antares Pharma, Inc. Transmucosal Drug Delivery Product Portfolio
  108. 6.18.5 Antares Pharma, Inc. Recent Developments
  109. 6.19 ALZA Corporation
  110. 6.19.1 ALZA Corporation Company Information
  111. 6.19.2 ALZA Corporation Business Overview
  112. 6.19.3 ALZA Corporation Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 ALZA Corporation Transmucosal Drug Delivery Product Portfolio
  114. 6.19.5 ALZA Corporation Recent Developments
  115. 6.20 Acrux Limited
  116. 6.20.1 Acrux Limited Company Information
  117. 6.20.2 Acrux Limited Business Overview
  118. 6.20.3 Acrux Limited Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Acrux Limited Transmucosal Drug Delivery Product Portfolio
  120. 6.20.5 Acrux Limited Recent Developments
  121. 6.21 3M Pharmaceuticals
  122. 6.21.1 3M Pharmaceuticals Company Information
  123. 6.21.2 3M Pharmaceuticals Business Overview
  124. 6.21.3 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 3M Pharmaceuticals Transmucosal Drug Delivery Product Portfolio
  126. 6.21.5 3M Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Transmucosal Drug Delivery Market Size by Country (2021-2026)
  3. 7.3 North America Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Transmucosal Drug Delivery Market Size by Country (2021-2026)
  3. 8.3 Europe Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Transmucosal Drug Delivery Market Size by Country (2021-2026)
  3. 10.3 South America Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Transmucosal Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Transmucosal Drug Delivery Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst